# Treatment Patterns And Outcomes In Patients Treated With Benefix Or Refacto/Refacto AF - A Swedish Cohort Study

> **NCT02740413** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 86 (actual)

## Conditions studied

- Hemophilia A
- Hemophilia B

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02740413
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01-11
- **Primary completion:** 2017-12-31
- **Final completion:** 2017-12-31
- **Target enrollment:** 86 (ACTUAL)
- **Last updated:** 2025-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02740413

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02740413, "Treatment Patterns And Outcomes In Patients Treated With Benefix Or Refacto/Refacto AF - A Swedish Cohort Study". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02740413. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*